GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine OH Miller, L Yang, CC Wang, EA Hargroder, Y Zhang, E Delpire, BJ Hall elife 3, e03581, 2014 | 377 | 2014 |
Two cellular hypotheses explaining the initiation of ketamine's antidepressant actions: Direct inhibition and disinhibition OH Miller, JT Moran, BJ Hall Neuropharmacology 100, 17-26, 2016 | 206 | 2016 |
Sustained NPY signaling enables AgRP neurons to drive feeding Y Chen, RA Essner, S Kosar, OH Miller, YC Lin, S Mesgarzadeh, ... Elife 8, e46348, 2019 | 110 | 2019 |
Microengineered peripheral nerve-on-a-chip for preclinical physiological testing RM Huval, OH Miller, JL Curley, Y Fan, BJ Hall, MJ Moore Lab on a Chip 15 (10), 2221-2232, 2015 | 78 | 2015 |
Synaptic regulation of a thalamocortical circuit controls depression-related behavior OH Miller, A Bruns, IB Ammar, T Mueggler, BJ Hall Cell reports 20 (8), 1867-1880, 2017 | 64 | 2017 |
Cross talk between glucocorticoid and estrogen receptors occurs at a subset of proinflammatory genes A Cvoro, C Yuan, S Paruthiyil, OH Miller, KR Yamamoto, DC Leitman The Journal of Immunology 186 (7), 4354-4360, 2011 | 63 | 2011 |
Genome-wide translating mRNA analysis following ketamine reveals novel targets for antidepressant treatment OH Miller, N Grabole, I Wells, BJ Hall BioRxiv, 254904, 2018 | 4 | 2018 |
In Vivo Cellular-Resolution Calcium Imaging Reveals Functional Biomarkers of the Antidepressant Ketamine and Guides Preclinical Efficacy Testing O Miller, L Bellier, S Huang, L Gray, J Nassi NEUROPSYCHOPHARMACOLOGY 48, 284-285, 2023 | | 2023 |